Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I)

Summary

The purpose of this study is to determine the effect of maraviroc therapy in obese insulin resistant subjects on: 1. Plasma triglyceride concentration 2. Plasma HDL-cholesterol and LDL-cholesterol concentrations 3. Plasma markers of cardiometabolic risk and inflammation

Timeline

Start

2011-01

Primary completion

2012-08

Completion

2012-11

Drugs

Indications